Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,583 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07072676Enrolling by invitation
Can a walker help prevent falls in neuromuscular disease?
This study tests if using assistive walking devices, after a short training period, can lower the risk of falls in people with neuromuscular diseases. It aims to help you stay steady and safe on your feet.
Bad FeilnbachAges 65–65 - NCT07036614Enrolling by invitation
New light tool for airway exams
This trial tests a special light device used during a lung airway exam (bronchoscopy) to help doctors see and biopsy growths more clearly. It might help people who are already scheduled for a bronchoscopy because of a spot on their chest x-ray or CT scan.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07033676Enrolling by invitation
Study of a blood marker for heart damage from high blood pressure
This trial looks at a substance in your blood called miR-455-5p to see if it can help doctors understand heart changes caused by high blood pressure. It involves people who have had high blood pressure for over a year and may have some heart symptoms.
Shenzhen, GuangdongAges 18 years+ - NCT07023965Enrolling by invitation
Long-term follow-up study for gene therapy in critical limb ischemia
This study follows up with people who previously took part in a clinical trial testing an experimental gene therapy for critical limb ischemia (severe leg pain or sores due to blocked arteries). It aims to see how well the treatment works over time. If you were in that earlier trial and received at least one dose, joining this follow-up could help researchers learn more about the therapy's lasting effects.
Beijing, Beijing MunicipalityAges 20–85 - NCT06999330Enrolling by invitation
TMS for anxiety in Parkinson's disease
This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain treatment, can help reduce anxiety in people with Parkinson's disease. You may qualify if you have both Parkinson's and significant anxiety symptoms.
Saint Paul, MinnesotaAges 40–90 - NCT06992284Enrolling by invitation
Heart disease study in Niigata
This study looks at the long-term outlook for people with heart disease in Niigata, Japan. It helps doctors learn more about what affects recovery and health over time.
Niigata, NiigataAges 18 years+ - NCT06963879Enrolling by invitation
Video game test and treatment for Alzheimer's disease
This study uses interactive video games to help diagnose and potentially treat early-stage Alzheimer's disease or mild cognitive impairment. It is testing whether these games can improve thinking skills.
Mataró, BarcelonaAges 50 years+ - NCT06960005Enrolling by invitation
Exercise to improve muscle and reduce falls in thyroid disease
This study tests whether a special exercise program can help older women with thyroid disease improve muscle strength, quality of life, and reduce falls. You would do supervised rhythm-based multitask exercises (like stepping and moving to music) several times a week.
GistrupAges 65 years+ - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT06958042Enrolling by invitation
Lung and bladder health study for COPD patients
This study looks at how common bladder problems are in people with stable COPD. It aims to help doctors better understand and manage these symptoms.
Kütahya, CenterAges 40–65 - NCT06951451Enrolling by invitation
Smartphone app to improve heart medication use in Oman
This study tests whether a smartphone app called MED-AD helps people in Oman with heart conditions take their medications more regularly. If you join, you'll use the app and the researchers will compare your medication habits to those who don't use it.
MuscatAges 18 years+ - NCT06944353Enrolling by invitation
Fatty liver risk screening in the emergency department
This study looks at fatty liver findings on emergency department scans. If you have fatty liver and were sent home from the ED, the study may help connect you to follow-up care and avoid future liver problems.
Chicago, IllinoisAges 18 years+ - NCT06942312Enrolling by invitation
Liver metabolism study in non-alcoholic fatty liver disease
This trial studies how the liver processes fat in people with non-alcoholic fatty liver disease (NAFLD). It uses MRI scans to look at liver metabolism, which may help doctors understand the disease better and find new treatments.
Helsinki, UusimaaAges 18–75 - NCT06940869Enrolling by invitation
Reproductive health registry for rheumatic conditions
This study creates a registry to better understand pregnancy outcomes in people with autoimmune or rheumatic conditions. If you are aged 12 to 55, can become pregnant (or are currently pregnant or planning a pregnancy), and receive care at Duke Health, you may be eligible to join.
Durham, North CarolinaAges 12–55 - NCT06933992Enrolling by invitation
Chocolate balloon for blocked leg arteries
This trial tests a special balloon called the Chocolate Balloon Catheter to open blocked leg arteries. It may help people with peripheral artery disease avoid more invasive surgery.
HangzhouAges 18–80 - NCT06931782Enrolling by invitation
AI for respiratory disease screening study
This trial tests whether an artificial intelligence (AI) tool can help prevent, diagnose, and triage respiratory diseases. It is open to adults without medical training who can follow a survey.
Guangzhou, GuangdongAges 18–75 - NCT06924333Enrolling by invitation
Skin bacteria study in eczema
This study looks at the bacteria and other tiny organisms living on your skin to learn more about skin conditions like eczema. It may help doctors understand why some people get these skin problems.
Lund, Skåne CountyAges 18 years+ - NCT06923735Enrolling by invitation
Nutrition app pilot for employee health checks
This pilot study tests a nutrition app to help employees manage conditions like high cholesterol, high blood pressure, weight issues, or type 2 diabetes. It is part of your regular occupational health check or dietitian visit.
KuopioAges 18–75 - NCT06910475Enrolling by invitation
Exercise and biomarker study to reduce toxins in kidney disease
This study tests whether a supervised exercise program can help reduce toxins in the blood for people with chronic kidney disease and metabolic syndrome. Researchers will also look at blood markers to understand how exercise affects the body.
Taguatinga, Federal DistrictAges 18 years+ - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT06898541Enrolling by invitation
A device to treat chest pain from small heart artery disease
This trial tests a device called the Coronary Sinus Reducer for people with chest pain caused by problems in the small arteries of the heart. The device is placed in a vein near the heart to improve blood flow and reduce symptoms.
RotterdamAges 40 years+ - NCT06888570Enrolling by invitation
Liver health study for children & young adults with Down syndrome
This study looks at how eating patterns and body composition relate to fatty liver in children and young adults with Trisomy 21 (Down syndrome) or other genetic intellectual disabilities. It may help understand who is at risk and how to prevent liver problems.
Madrid, MadridAges 5–22 - NCT06885138Enrolling by invitation
Testing brain stimulation for depression in Parkinson's disease
This trial tests if a gentle brain stimulation technique called tDCS can improve depression symptoms in people with Parkinson's disease. You'll receive either real or placebo stimulation over several sessions to see if it helps your mood.
MilanAges 35–75 - NCT06880250Enrolling by invitation
Enzyme therapy study for Fabry disease patients
This trial tests if enzyme replacement therapy works well and is safe for Fabry disease. It is for people who are already prescribed this treatment.
AstrakhanAges 8–65
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,583 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.